Danelfinは、投資家がより賢明でデータに基づいた意思決定を行えるよう支援するAI搭載の株式分析プラットフォームです。毎日、株式やETFの何千もの特徴を分析し、今後3ヶ月で市場を上回る確率を予測するシンプルなAIスコア(1-10)を提供します。
Morphlinは、暗号資産トレーダーを支援するために設計されたAI搭載のトレーディングプラットフォームです。市場シグナル、MorphlinGPTによるポートフォリオ分析、専門的なリサーチレポートなどのインテリジェントなツールを提供し、ユーザーがBinanceなどの取引所でより賢く、効率的な取引決定を下すのを助けます。
製品概要
danelfin 製品概要
Danelfinは、投資家がより賢明でデータに基づいた意思決定を行えるよう支援するAI搭載の株式分析プラットフォームです。毎日、株式やETFの何千もの特徴を分析し、今後3ヶ月で市場を上回る確率を予測するシンプルなAIスコア(1-10)を提供します。
Morphlin 製品概要
Morphlinは、暗号資産トレーダーを支援するために設計されたAI搭載のトレーディングプラットフォームです。市場シグナル、MorphlinGPTによるポートフォリオ分析、専門的なリサーチレポートなどのインテリジェントなツールを提供し、ユーザーがBinanceなどの取引所でより賢く、効率的な取引決定を下すのを助けます。
Detailed feature comparison
| Feature | danelfin | Morphlin |
|---|---|---|
| 主要カテゴリー | 投資 | 暗号資産取引 |
| 追加日 | 2025-08-08 | 2025-08-05 |
| 価格 | フリーミアム | フリーミアム |
| 公式サイト | danelfin.com | www.morphlin.com |
| 製品タイプ | ウェブサイト | ウェブサイト |
| Performance data | ||
| ユーザー評価 | 未確認 | 未確認 |
| コメント | 0 | 0 |
| 月間訪問数 | 400.1K | 88 |
| 月間成長率 | 39.4% | 25.7% |
| お気に入り | 117 | 108 |
| Details | 詳細を見る | 詳細を見る |
danelfin vs Morphlin monthly traffic
Compare danelfin and Morphlin by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the danelfin vs Morphlin monthly traffic comparison, danelfin currently shows 400.1K visits and Morphlin shows 88; danelfin has about 4,547.1 times the visible traffic of Morphlin, an absolute difference of about 400.1K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
danelfin monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 217.2K 月間訪問数
- 2026/1: 328.7K 月間訪問数
- 2026/2: 294.2K 月間訪問数
- 2026/3: 266.9K 月間訪問数
- 2026/4: 287.1K 月間訪問数
- 2026/5: 400.1K 月間訪問数
主要地域
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 54.24% | 217K |
| 🇨🇦Canada | 15.47% | 61.9K |
| 🇳🇿New Zealand | 14.49% | 58K |
| 🇬🇧United Kingdom | 10.59% | 42.4K |
| 🇳🇱Netherlands | 5.21% | 20.8K |
流入元
| Source type | Percentage | Traffic |
|---|---|---|
| ダイレクト | 78.8% | 315.3K |
| Eメール | 11.58% | 46.3K |
| 参照元 | 9.62% | 38.5K |
検索キーワード
Morphlin monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/8: 0 月間訪問数
- 2025/9: 421 月間訪問数
- 2026/2: 0 月間訪問数
- 2026/3: 0 月間訪問数
- 2026/4: 70 月間訪問数
- 2026/5: 88 月間訪問数
検索キーワード
Usage comparison
Compare the core capabilities of danelfin and Morphlin
danelfin Core features
Morphlin Core features
Use cases
danelfin Use cases
Morphlin Use cases
danelfin vs Morphlin:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth danelfin vs Morphlin comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. danelfin is primarily listed under “投資”, while Morphlin is primarily listed under “暗号資産取引”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (danelfin: 投資; Morphlin: 暗号資産取引); Monthly visits (danelfin: 400.1K; Morphlin: 88); Monthly growth (danelfin: 39.4%; Morphlin: 25.7%); Favorites (danelfin: 117; Morphlin: 108); Website (danelfin: danelfin.com; Morphlin: www.morphlin.com). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the danelfin vs Morphlin monthly traffic comparison, danelfin currently shows 400.1K visits and Morphlin shows 88; danelfin has about 4,547.1 times the visible traffic of Morphlin, an absolute difference of about 400.1K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
If public market visibility is an important first-pass criterion, investigate danelfin first. The final choice should still follow taxonomy, use case, and a real trial because higher traffic does not prove broader capabilities or better workflow fit.
Product positioning, use cases, and roles
danelfin and Morphlin currently overlap in shared categories: 投資、データ分析; shared tags: 財務分析、投資、ポートフォリオ管理. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
danelfin's unique categories/tags are 株式分析、AI株式選定ツール、データ駆動型投資、ETF分析、市場予測、トレードアイデア; Morphlin's are 暗号資産取引、AIトレーディングボット、バイナンス、GPT、市場分析、トレーディングシグナル. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
danelfin has no verified rating, 0 comments, 117 favorites, and 104 likes;Morphlin has no verified rating, 0 comments, 108 favorites, and 114 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate danelfin first
Put danelfin on the priority trial list when the task aligns with “投資” and especially 株式分析、AI株式選定ツール、データ駆動型投資、ETF分析、市場予測、トレードアイデア. This follows recorded positioning and does not imply unlisted capabilities are absent.
danelfin also currently records: pricing is freemium, product type is website, 400.1K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate Morphlin first
Put Morphlin on the priority trial list when the task aligns with “暗号資産取引” and especially 暗号資産取引、AIトレーディングボット、バイナンス、GPT、市場分析、トレーディングシグナル. This follows recorded positioning and does not imply unlisted capabilities are absent.
Morphlin also currently records: pricing is freemium, product type is website, 88 verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in danelfin and Morphlin, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




